Zimmer Biomet Holdings EBIT

Zimmer Biomet Holdings (ZBH) currently reports a EBIT of $1.3B as of June 2026. That compares with $140M in the prior-year period — up 839.1% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Zimmer Biomet Holdings's EBIT history and peer comparisons.

Zimmer Biomet Holdings's EBIT increased from $140M to $1.3B — a 839.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zimmer Biomet Holdings's EBIT of $1.3B is lower than the Healthcare sector average of $22B. That is roughly 94.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Zimmer Biomet Holdings reported $1.3B in EBIT as of June 2026. That compares with $140M in the prior-year period — up 839.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $1.3B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Zimmer Biomet Holdings, and consider following ZBH for alerts when major investors trade the stock.